Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-British grandma is 1st in world to get Pfizer vaccine outside trial

Tue, 08th Dec 2020 07:09

* 90-year-old grandmother gets Pfizer vaccine

* Britain rolls out COVID vaccine, first in the West

* 'I feel so privileged' says first vaccine recipient
(Adds details, UK context)

By Kate Holton

LONDON, Dec 8 (Reuters) - Margaret Keenan, a 90-year-old
grandmother, on Tuesday became the first person in the world to
receive the Pfizer COVID-19 vaccine shot outside of a
trial as Britain began vaccinating its population.

An early riser, Keenan received the vaccine at her local
hospital in Coventry, central England, on Tuesday morning at
0631 GMT, a week before she turns 91.

Britain began rolling out the COVID-19 vaccine developed by
Pfizer and BioNTech on Tuesday, the first Western country to
start vaccinating its general population in what was hailed as a
decisive watershed in defeating the coronavirus.

"I feel so privileged to be the first person vaccinated
against Covid-19," said Keenan, as she received the jab from a
nurse originally from the Philippines in front of a photographer
and TV crew.

"It's the best early birthday present I could wish for
because it means I can finally look forward to spending time
with my family and friends in the New Year after being on my own
for most of the year."

Keenan, known as Maggie to her friends, is a former
jewellery shop assistant who only retired four years ago. She
has a daughter, a son and four grandchildren.

Video footage shows her wearing a medical mask along with a
blue t-shirt and cardigan while she receives the shot from nurse
May Parsons.

Parsons, who has worked in Britain's National Health Service
for 24 years, said the last few months had been tough on
everyone but it felt like there was now light at the end of the
tunnel.

Britain is the worst-hit European country from COVID-19,
with over 61,000 deaths, but Prime Minister Boris Johnson hopes
to turn the tide against the disease by rolling out the
Pfizer/BioNTech vaccine before the United States or European
Union.

The mass inoculation will fuel hope that the world may be
turning a corner in the fight against a pandemic that has
crushed economies and killed more than 1.5 million, although
ultra-cold storage and tricky logistics will limit its use for
now.

British Health Secretary Matt Hancock and Stephen Powis,
medical director for NHS England, said they both found it very
emotional watching the vaccine programme roll out.

The BBC also carried an interview with another elderly lady
who will receive the vaccine today, very upset after she lost
her husband from COVID-19 earlier in the year.

Britain has ordered 40 million doses of the Pfizer/BioNTech
shot. As each person requires two doses, that is enough to
vaccinate 20 million people in the country of 67 million.

About 800,000 doses are expected to be available within the
first week, with care home residents and carers, the over 80s
and some health service workers the top priority to get them.
(Reporting by Kate Holton, editing by Estelle Shirbon/Guy
Faulconbridge)

More News
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.